KLK3 and esophageal adenocarcinoma: Oesophageal adenocarcinoma in men and women (BMI); melanoma, men (BMI); endometrial cancer (HC per 10 cm); postmenopausal endometrial cancer, never HRT use (BMI and WG); postmenopausal endometrial cancer, ever HRT use (BMI and WG); endometrial cancer mortality (BMI); ovarian cancer (weight per 5 kg); postmenopausal ovarian cancer, never HRT use (WG); prostate cancer, advanced (BMI); prostate cancer, countries with high screening rate for prostate specific antigen (WG); thyroid cancer, men (BMI); non-Hodgkin’s lymphoma mortality (BMI); leukaemia, men and women (BMI)